Industry News

Exosome Diagnostics Announces Positive Results from Large Clinical Validation Study of Prostate Cancer Liquid Biopsy

exosome rna

Novel urine-based test demonstrates ability to accurately predict high-grade prostate cancer; holds potential to advance new prognostic paradigm, reduce unnecessary tissue biopsies NEW ORLEANS, La., and CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced ...

Read More »

Exosome Diagnostics Announces Positive Results from Initial Clinical Study of Novel Prostate Cancer Liquid Biopsy

exosome rna

Data Demonstrate Non-Invasive, Urine-Based Test’s Ability to Predict High-Grade Prostate Cancer By Analyzing Biomarkers on Exosomal RNA (exoRNA) ORLANDO, Fla. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced positive data from an initial ...

Read More »

Exosome Diagnostics and the Addario Lung Cancer Medical Institute (ALCMI) to Collaborate on Development of Liquid Biopsy Cancer Diagnostics

exosome rna

Clinical testing underway utilizing matched samples from ALCMI’s Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Trial Collaboration will support validation for Exosome Diagnostics’ ALK and T790M plasma-based diagnostics planned to launch in 2015 Novel biofluid-based diagnostics offer the potential to ...

Read More »